Skip to content
TrialScanner

NCT06120075

A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies

Phase 1CompletedRCUSLead

Registry record

Lead sponsor
Arcus Biosciences, Inc.
Conditions
Advanced Cancer
Primary completion
Apr 29, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06120075 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.